 Zynerba Pharmaceuticals, Inc. NASDAQ:ZYNE disclosed Wednesday its first-quarter net loss of 8.0 million or a loss of 20 cents per share, compared to 12.34 million in the same period of 2020 or a loss of 53 cents per share. First Quarter Highlights 